...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: The crick didn’t rise, here’s the presentation, finally!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Ugh.

I guarantee we will still be here 6, 12, 24 months down the line. Or I'll eat my hat.

Cenora is there to advise on development and market. A buyer from a big pharm has that expertise in house (or on speed dial) and doesn't need it packaged into a deal.

Don's nose is longer than Pinnochio...the man's a salesman. In the words of Narmac -- "or haven't you noticed?"

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply